The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Rare Saposin A deficiency: Novel variant and psychosine analysis
Abstract
Saposin A is a post-translation product of the prosaposin (PSAP) gene that serves as an activator protein of the galactocerebrosidase (GALC) enzyme, and is necessary for the degradation of certain glycosphingolipids. Deficiency of saposin A leads to a clinical picture identical to that of early-infantile Krabbe disease caused by GALC enzyme deficiency. Galactosylsphingosine, also known as psychosine, is a substrate of the GALC enzyme that is known to be elevated in classic Krabbe disease. We present the case of an 18-month-old male with clinical and radiological findings concerning for Krabbe disease who had preserved GALC enzyme activity and negative GALC gene sequencing, but was found to have a homozygous variant, c.257 T > A (p.I86N), in the saposin A peptide of PSAP. Psychosine determination on dried blood spot at 18 months of age was elevated to 12 nmol/L (normal <3 nmol/L). We present this case to add to the literature on the rare diagnosis of atypical Krabbe disease due to saposin A deficiency, to report a novel presumed pathogenic variant within PSAP, and to suggest that individuals with saposin A deficiency may have elevated levels of psychosine, similar to children with classic Krabbe disease due to GALC deficiency.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Genetic PSAP deficiency in humans also causes various forms of progressive neurodegenerative conditions depending on the type of mutation in the PSAP gene (48–51).”
From Treatment of a genetic brain disease by CNS-wide microglia replacement (2022) · cites this paper as [48]
Citations
Cites
Spiegel, R., Bach, G., Sury, V., Mengistu, G., Meidan, B., Shalev, S., Shneor, Y., Mandel, H., & Zeigler, M. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.10.004 · Cited by 129
Research works printed but not linked: 13
- Matsuda, 2001, A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene results in a late- onset, chronic form of globoid cell leukodystrophy in the mouse, Hum. Mol. Genet., 10, 1191, 10.1093/hmg/10.11.1191 · DOI
- Escolar, 2005, Transplantation of umbilical-cord blood in babies with infantile Krabbe’s disease, N. Engl. J. Med., 352, 2069, 10.1056/NEJMoa042604 · DOI
- Wright, 2017, Developmental outcomes of cord blood transplantation for Krabbe disease, Neurology., 89, 1365, 10.1212/WNL.0000000000004418 · DOI
- Orsini, 2016, Newborn screening for Krabbe disease in New York state: the first eight years’ experience, Genet. Med., 10.1038/gim.2015.211 · DOI
- Zanfini, 2013, Quantification of psychosine in the serum of twitcher mouse by LC–ESI-tandem-MS analysis, J. Pharm. Biomed. Anal., 80, 44, 10.1016/j.jpba.2013.02.039 · DOI
- Chuang, 2013, Determination of psychosine concentration in dried blood spots from newborns that were identified via newborn screening to be at risk for Krabbe disease, Clin. Chim. Acta, 419, 73, 10.1016/j.cca.2013.01.017 · DOI
- Escolar, 2017, Psychosine, a marker of Krabbe phenotype and treatment effect, Mol. Genet. Metab., 10.1016/j.ymgme.2017.05.015 · DOI
- Turgeon, 2015, Measurement of psychosine in dried blood spots — a possible improvement to newborn screening programs for Krabbe disease, J. Inherit. Metab. Dis., 10.1007/s10545-015-9822-z · DOI
- Minter Baerg, 2018, Precision newborn screening for lysosomal disorders, Genet. Med., 20, 847, 10.1038/gim.2017.194 · DOI
- Kwon, 2018, Consensus guidelines for newborn screening, diagnosis and treatment of infantile Krabbe disease, Orphanet. J Rare Dis., 13, 30, 10.1186/s13023-018-0766-x · DOI
- Suzuki, 2016, My encounters with Krabbe disease: a personal recollection of a 40-year journey with young colleagues, J. Neurosci. Res., 10.1002/jnr.23735 · DOI
- Puckett, 2012, Krabbe disease: clinical, biochemical and molecular information on six new patients and successful retrospective diagnosis using stored newborn screening cards, Mol. Genet. Metab., 105, 126, 10.1016/j.ymgme.2011.10.010 · DOI
- Hill, 2018, The mechanism of glycosphingolipid degredation revealed by a GALC-SapA complex structure, Nat. Commun., 9, 10.1038/s41467-017-02361-y · DOI
Cited by
Treatment of a genetic brain disease by CNS-wide microglia replacement
Shibuya, Y., Kumar, K. K., Mader, M. M.-D., Yoo, Y., Ayala, L. A., Zhou, M., Mohr, M. A., Neumayer, G., Kumar, I., Yamamoto, R., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abl9945 · Cited by 126
Metadata
- Authors
- Calderwood, L., Wenger, D. A., Matern, D., Dahmoush, H., Watiker, V., & Lee, C.
- Venue
- Molecular Genetics and Metabolism
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 129
- Issue
- 2
- Pages
- 161-164
- ISSN
- 1096-7192
- Cited by
- 18
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Rare Saposin A deficiency: Novel variant and psychosine analysis. https://app.cochat.ai/papers/10.1016/j.ymgme.2019.08.001
- The paper
- Calderwood, L., Wenger, D. A., Matern, D., Dahmoush, H., Watiker, V., & Lee, C. (2020). Rare Saposin A deficiency: Novel variant and psychosine analysis. Molecular Genetics and Metabolism. https://doi.org/10.1016/j.ymgme.2019.08.001